Non-Invasive Treatment of Fascia
First Claim
Patent Images
1. A method for non-invasive treatment and prevention of fascial conditions, comprising:
- providing an acoustic wave source effective to deliver a focused acoustic wave to a target site within a patient'"'"'s body; and
focusing an acoustic wave through a patient'"'"'s skin to fenestrate in a desired pattern at least one location in the patient'"'"'s fascia.The method of claim 0, further applying a medium to the patient'"'"'s skin adjacent to the target site.The method of claim 0, further comprising non-destructible heating of tissue adjacent to the target site.The method of claim 0, further comprising imaging the fascia using an imaging source that is integrated with the acoustic wave source.The method of claim 0, wherein the imaging source is an ultrasound source.The method of claim 0, wherein the acoustic wave is delivered to the target site at a frequency in the range of about 0.5 MHz to 5 MHz.The method of claim 0, wherein the acoustic wave is delivered to the target site at a frequency in the range of about 1 MHz.The method of claim 0, wherein the acoustic wave source is focused to form a focal spot in the range of about 0.3 mm to 3.0 mm.The method of claim 0, further comprising adjusting the acoustic source in the range of about 10 W to 100 W prior to fenestration of the fascia.The method of claim 0, wherein the frequency of the acoustic wave source is adjusted to the range of about 10 W to 20 W prior to fenestration of the fascia.A method for non-invasive treatment and prevention of compartment syndrome, comprising;
inducing cavation into a target region via an acoustic treatment source;
focusing the acoustic treatment source; and
adjusting a frequency of the acoustic treatment source such that the target region is penetrated.The method of claim 0, further comprising imaging the target region using an imaging device that is integrated with the acoustic treatment source.The method of claim 0, wherein the imaging device is an ultrasound source.The method of claim 0, further comprising moving the acoustic treatment source such that cuts or a pattern of fenestrations are formed on the target region.The method of claim 0, wherein the step of inducing cavation further includes generating acoustic waves in the range of about 0.5 MHz to 5 MHz.The method of claim 0, wherein the step of inducing cavation further includes generating acoustic waves in the range of about 1 MHz.The method of claim 0, wherein the treatment source is focused to form a focal spot on the target region in the range of about 0.3 mm to 3.0 mm.The method of claim 0, wherein the frequency of the treatment source is adjusted to the range of about 10 W to 100 W.The method of claim 0, wherein the frequency of the treatment source is adjusted to the range of about 0 W to 20 W.
3 Assignments
0 Petitions
Accused Products
Abstract
Various methods and devices for minimally invasive treatment and prevention of conditions of the fascia are provided. In one aspect, a method includes providing an acoustic wave source effective to deliver a focused acoustic wave to a target site within a patient'"'"'s body, and focusing an acoustic wave through a patient'"'"'s skin such that at least one location in the patient'"'"'s fascia is fenestrated in a desired pattern.
131 Citations
1 Claim
-
1. A method for non-invasive treatment and prevention of fascial conditions, comprising:
-
providing an acoustic wave source effective to deliver a focused acoustic wave to a target site within a patient'"'"'s body; and focusing an acoustic wave through a patient'"'"'s skin to fenestrate in a desired pattern at least one location in the patient'"'"'s fascia. The method of claim 0, further applying a medium to the patient'"'"'s skin adjacent to the target site. The method of claim 0, further comprising non-destructible heating of tissue adjacent to the target site. The method of claim 0, further comprising imaging the fascia using an imaging source that is integrated with the acoustic wave source. The method of claim 0, wherein the imaging source is an ultrasound source. The method of claim 0, wherein the acoustic wave is delivered to the target site at a frequency in the range of about 0.5 MHz to 5 MHz. The method of claim 0, wherein the acoustic wave is delivered to the target site at a frequency in the range of about 1 MHz. The method of claim 0, wherein the acoustic wave source is focused to form a focal spot in the range of about 0.3 mm to 3.0 mm. The method of claim 0, further comprising adjusting the acoustic source in the range of about 10 W to 100 W prior to fenestration of the fascia. The method of claim 0, wherein the frequency of the acoustic wave source is adjusted to the range of about 10 W to 20 W prior to fenestration of the fascia. A method for non-invasive treatment and prevention of compartment syndrome, comprising; inducing cavation into a target region via an acoustic treatment source; focusing the acoustic treatment source; and adjusting a frequency of the acoustic treatment source such that the target region is penetrated. The method of claim 0, further comprising imaging the target region using an imaging device that is integrated with the acoustic treatment source. The method of claim 0, wherein the imaging device is an ultrasound source. The method of claim 0, further comprising moving the acoustic treatment source such that cuts or a pattern of fenestrations are formed on the target region. The method of claim 0, wherein the step of inducing cavation further includes generating acoustic waves in the range of about 0.5 MHz to 5 MHz. The method of claim 0, wherein the step of inducing cavation further includes generating acoustic waves in the range of about 1 MHz. The method of claim 0, wherein the treatment source is focused to form a focal spot on the target region in the range of about 0.3 mm to 3.0 mm. The method of claim 0, wherein the frequency of the treatment source is adjusted to the range of about 10 W to 100 W. The method of claim 0, wherein the frequency of the treatment source is adjusted to the range of about 0 W to 20 W.
-
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeThe General Hospital Corporation (Mass General Brigham, Inc.)
-
Original AssigneeThe General Hospital Corporation (Mass General Brigham, Inc.)
-
InventorsAnderson, Richard Rox, Parrish, John A., Vosburgh, Kirby
-
Granted Patent
-
Time in Patent OfficeDays
-
Field of Search
-
US Class Current600/439
-
CPC Class CodesA61B 2090/378 using ultrasoundA61B 8/06 Measuring blood flow measur...A61B 8/13 Tomography A61B8/10, A61B8/...A61B 8/14 Echo-tomographyA61N 7/00 Ultrasound therapy lithotri...A61N 7/02 Localised ultrasound hypert...
